Total Payments
$358,561
2024 Payments
$6,866
Companies
51
Transactions
532
Medicare Patients
3,773
Medicare Billing
$489,768
Payment Breakdown by Category
Consulting$162,040 (45.2%)
Research$128,650 (35.9%)
Other$53,157 (14.8%)
Food & Beverage$8,668 (2.4%)
Travel$6,012 (1.7%)
Education$33.98 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $162,040 | 10 | 45.2% |
| Unspecified | $128,650 | 3 | 35.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,157 | 25 | 14.8% |
| Food and Beverage | $8,668 | 466 | 2.4% |
| Travel and Lodging | $6,012 | 24 | 1.7% |
| Education | $33.98 | 4 | 0.0% |
Payments by Type
General
$229,911
529 transactions
Research
$128,650
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ModernaTX, Inc. | $276,650 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $65,252 | 109 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $7,746 | 13 | $0 (2020) |
| GlaxoSmithKline, LLC. | $1,784 | 142 | $0 (2024) |
| Olympus Corporation of the Americas | $1,454 | 15 | $0 (2020) |
| Ethicon Inc. | $1,310 | 5 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $406.84 | 39 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $357.39 | 24 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $340.19 | 13 | $0 (2023) |
| Medical Device Business Services, Inc. | $284.48 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,866 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($6,051) |
| 2023 | $162,028 | 45 | ModernaTX, Inc. ($148,000) |
| 2022 | $136,430 | 40 | ModernaTX, Inc. ($128,650) |
| 2021 | $836.17 | 59 | AstraZeneca Pharmaceuticals LP ($151.11) |
| 2020 | $7,516 | 60 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,104) |
| 2019 | $13,550 | 83 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,343) |
| 2018 | $16,853 | 110 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,108) |
| 2017 | $14,481 | 98 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,042) |
All Payment Transactions
532 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/13/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/02/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $22.42 | General |
| 11/02/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $22.10 | General |
| 11/02/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $14.48 | General |
| 11/01/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $225.48 | General |
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.78 | General |
| 10/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.40 | General |
| 09/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $105.21 | General |
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $134.00 | General |
| 06/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: IMMUNOLOGY | ||||||
| 06/09/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: NEUROLOGY | ||||||
| 06/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,350.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older | ModernaTX, Inc. | $128,650 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 842 | 1,315 | $252,727 | $108,213 |
| 2022 | 18 | 765 | 1,296 | $227,883 | $107,694 |
| 2021 | 23 | 956 | 1,612 | $258,462 | $132,017 |
| 2020 | 30 | 1,210 | 1,979 | $293,253 | $141,844 |
Total Patients
3,773
Total Services
6,202
Medicare Billing
$489,768
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 367 | $58,770 | $32,584 | 55.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 76 | 181 | $61,540 | $29,166 | 47.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 118 | 223 | $45,492 | $20,078 | 44.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 87 | 91 | $24,570 | $11,835 | 48.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 44 | $5,707 | $2,616 | 45.8% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 23 | 24 | $12,720 | $1,768 | 13.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $3,000 | $1,746 | 58.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 39 | 40 | $3,800 | $1,429 | 37.6% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 11 | 12 | $14,400 | $991.56 | 6.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 13 | 13 | $1,040 | $935.09 | 89.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 27 | 27 | $2,565 | $919.91 | 35.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 90 | $1,080 | $748.58 | 69.3% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 14 | 18 | $810.00 | $692.46 | 85.5% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 28 | 31 | $9,300 | $674.73 | 7.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 24 | 25 | $2,275 | $542.47 | 23.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 17 | $1,768 | $402.97 | 22.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $490.00 | $400.82 | 81.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 11 | 12 | $2,100 | $337.56 | 16.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 13 | 16 | $480.00 | $132.64 | 27.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 12 | 15 | $390.00 | $114.15 | 29.3% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 40 | 43 | $430.00 | $97.78 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 405 | $64,850 | $36,614 | 56.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 76 | 178 | $60,520 | $29,770 | 49.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 127 | 248 | $50,592 | $19,732 | 39.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 51 | $13,770 | $7,905 | 57.4% |
About Dr. Sandeep Kukreja, M.D
Dr. Sandeep Kukreja, M.D is a Critical Care Medicine healthcare provider based in Greenwood, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992906846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Kukreja, M.D has received a total of $358,561 in payments from pharmaceutical and medical device companies, with $6,866 received in 2024. These payments were reported across 532 transactions from 51 companies. The most common payment nature is "Consulting Fee" ($162,040).
As a Medicare-enrolled provider, Kukreja has provided services to 3,773 Medicare beneficiaries, totaling 6,202 services with total Medicare billing of $489,768. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Greenwood, IN
- Active Since 05/29/2007
- Last Updated 05/09/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1992906846
Products in Payments
- Moderna Covid-19 Vaccine (Biological) $276,650
- OFEV (Drug) $30,738
- Adempas (Drug) $7,746
- Monarch Platform (Device) $1,310
- NUCALA (Biological) $1,091
- EVIS EXERA (Device) $753.62
- Olympus Bronchoscopes (Device) $700.38
- TRELEGY ELLIPTA (Drug) $406.71
- XARELTO (Drug) $327.84
- DUPIXENT (Biological) $233.88
- FlowTriever (Device) $185.30
- Utibron (Drug) $150.67
- OPSUMIT MACITENTAN (Drug) $146.45
- LONHALA MAGNAIR (Drug) $144.62
- BREZTRI (Drug) $122.89
- ANORO (Drug) $122.16
- Solitaire (Device) $118.19
- STIOLTO RESPIMAT (Drug) $112.27
- ENTRESTO (Drug) $104.93
- Wellcentive Undiv (Device) $91.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Greenwood
Dr. Faisal Khan, Md, MD
Critical Care Medicine — Payments: $169,121
Critical Care Medicine $169,121
Dr. Imad Shawa, Md, MD
Critical Care Medicine — Payments: $28,103
Critical Care Medicine $28,103
Dr. Aaron Bruns, M.d, M.D
Critical Care Medicine — Payments: $4,727
Critical Care Medicine $4,727
Dr. Winston Nara, Md, MD
Critical Care Medicine — Payments: $3,963
Critical Care Medicine $3,963
Dr. Ruxandra Ionescu, Md, MD
Critical Care Medicine — Payments: $1,763
Critical Care Medicine $1,763
Melinda Quarles, Msn, Rn, MSN, RN
Critical Care Medicine — Payments: $368.07
Critical Care Medicine $368.07